Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MA
|
Marc Olivie
Director |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 20.76% |
$1,012,920
$84.41 p/Share
|
Jan 05
2015 |
|
FCNCA
|
Holding Frank B Jr
Chairman and CEO |
BUY
Open market or private purchase
|
Direct | 576 Added 0.59% |
$131,904
$229.0 p/Share
|
Jan 05
2015 |
|
CVS
|
Larry J Merlo
Director |
SELL
Open market or private sale
|
Direct | 144,144 Reduced 65.44% |
$13,592,780
$94.3 p/Share
|
Jan 05
2015 |
|
CVS
|
Larry J Merlo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 144,144 Added 39.55% |
$5,934,408
$41.17 p/Share
|
Jan 05
2015 |
|
FCNCA
|
Bryant Hope Holding
Vice Chairwoman |
BUY
Bona fide gift
|
Direct | 125 Added 0.12% |
-
|
Jan 03
2015 |
|
CSCO
|
Mark D Chandler
EVP, LglSrvs & GenCnsl |
BUY
Bona fide gift
|
Indirect | 9,888 Added 7.31% |
-
|
Jan 02
2015 |
|
CSCO
|
Mark D Chandler
EVP, LglSrvs & GenCnsl |
SELL
Bona fide gift
|
Direct | 9,888 Reduced 4.62% |
-
|
Jan 02
2015 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Direct | 8,600 Reduced 3.39% |
$174,236
$20.26 p/Share
|
Jan 02
2015 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 8,600 Added 3.28% |
$87,720
$10.2 p/Share
|
Jan 02
2015 |
|
ENPH
|
Jeff Loebbaka
VP, Worldwide Sales |
SELL
Open market or private sale
|
Direct | 5,320 Reduced 4.77% |
$76,076
$14.3 p/Share
|
Jan 02
2015 |
|
ENPH
|
Jeff Loebbaka
VP, Worldwide Sales |
BUY
Exercise of conversion of derivative security
|
Direct | 5,320 Added 4.55% |
$8,672
$1.63 p/Share
|
Jan 02
2015 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 26,353 Reduced 22.94% |
$337,318
$12.8 p/Share
|
Jan 02
2015 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 81,675 Added 41.55% |
-
|
Jan 02
2015 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,753 Reduced 7.88% |
$112,038
$12.8 p/Share
|
Jan 02
2015 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 26,750 Added 19.41% |
-
|
Jan 02
2015 |
|
R
|
Robert Hagemann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 704 Added 36.29% |
$64,965
$92.28 p/Share
|
Jan 02
2015 |
|
NCLH
|
John Chidsey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,605 Added 16.22% |
-
|
Jan 02
2015 |
|
NCLH
|
Walter L Revell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,140 Added 14.45% |
-
|
Jan 02
2015 |
|
NCLH
|
F Robert Salerno
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,070 Added 14.05% |
-
|
Jan 02
2015 |
|
FDX
|
Frederick W Smith
Executive Chairman |
SELL
Bona fide gift
|
Direct | 119,947 Reduced 0.78% |
-
|
Jan 02
2015 |
|
CVS
|
Per Gh Lofberg
EVP |
SELL
Open market or private sale
|
Direct | 347,343 Reduced 93.68% |
$33,094,841
$95.28 p/Share
|
Jan 02
2015 |
|
CVS
|
Per Gh Lofberg
EVP |
BUY
Exercise of conversion of derivative security
|
Direct | 347,343 Added 48.37% |
$15,654,749
$45.07 p/Share
|
Jan 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 50,240 Reduced 54.91% |
$4,808,470
$95.71 p/Share
|
Jan 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 50,240 Added 35.45% |
$1,756,390
$34.96 p/Share
|
Jan 02
2015 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
SELL
Open market or private sale
|
Direct | 4,220 Reduced 59.97% |
$403,727
$95.67 p/Share
|
Jan 02
2015 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 36,762 Reduced 12.42% |
$2,683,994
$73.01 p/Share
|
Jan 02
2015 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 36,762 Added 11.05% |
$1,255,790
$34.16 p/Share
|
Jan 02
2015 |
|
ORCL
|
Mark V Hurd
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 375,000 Reduced 99.73% |
$16,713,750
$44.57 p/Share
|
Jan 02
2015 |
|
ORCL
|
Mark V Hurd
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 375,000 Added 49.93% |
$9,052,500
$24.14 p/Share
|
Jan 02
2015 |
|
LGF-B
|
Wayne Levin
General Counsel and CSO |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 10.17% |
$395,375
$31.63 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 11,500 Added 42.06% |
$297,850
$25.9 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
SELL
Open market or private sale
|
Direct | 11,500 Reduced 72.6% |
$1,055,585
$91.79 p/Share
|
Jan 02
2015 |
|
IDCC
|
Lawrence F Shay
SEVP,Fut.Wireless,&Ch.IPCouns. |
SELL
Open market or private sale
|
Direct | 7,036 Reduced 12.49% |
$369,601
$52.53 p/Share
|
Jan 02
2015 |
|
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 13.24% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,008 Added 3.05% |
$17,499
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 4.81% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 4.73% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 3.08% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 2.97% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,341 Added 50.0% |
-
|
Jan 01
2015 |
|
PLXS
|
Stephen P Cortinovis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,257 Added 20.99% |
-
|
Jan 01
2015 |
|
PLXS
|
Mary A Winston
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 15.89% |
-
|
Jan 01
2015 |
|
SPOK
|
Gary Ash
Global VP of Sales |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Colin Balmforth
President of USA Mobility Wire |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Danielle Brogan
Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Sean Collins
SVP of Sales |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Bonnie Culp Fingerhut
Ex. VP, HR & Adminstration |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Shawn Eric Endsley
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Hemant Goel
President of Spok, Inc. |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Vincent D Kelly
President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 0 Added 0.0% |
-
|
Jan 01
2015 |